MedPath

StemCells, Inc.

🇺🇸United States
Ownership
Private, Subsidiary
Established
1992-01-01
Employees
-
Market Cap
-
Website
http://stemcellsinc.com

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

Phase 2
Terminated
Conditions
Age-Related Macular Degeneration
Interventions
Biological: HuCNS-SC sub-retinal transplantation
First Posted Date
2015-06-10
Last Posted Date
2016-06-02
Lead Sponsor
StemCells, Inc.
Target Recruit Count
3
Registration Number
NCT02467634
Locations
🇺🇸

Retina Vitreous Associates Medical Group, Beverly Hills, California, United States

🇺🇸

Retinal Diagnostic Center, Campbell, California, United States

🇺🇸

Retina Research Institute of Texas, Abilene, Texas, United States

and more 8 locations

Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury

Phase 2
Terminated
Conditions
Spine Injury
Cervical Spine Injury
Cervical Spinal Cord Injury
Interventions
Drug: HuCNS-SC cells
First Posted Date
2014-06-16
Last Posted Date
2016-06-02
Lead Sponsor
StemCells, Inc.
Target Recruit Count
31
Registration Number
NCT02163876
Locations
🇺🇸

Mount Sinai Medical Center, Dept of Neurosurgery, New York, New York, United States

🇺🇸

Rancho Los Amigos National Rehabilitation Center/USC, Downey, California, United States

🇨🇦

Foothills Medical Center, Calgary, Alberta, Canada

and more 11 locations

Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Terminated
Conditions
Geographic Atrophy
Age-Related Macular Degeneration
First Posted Date
2014-05-14
Last Posted Date
2016-06-02
Lead Sponsor
StemCells, Inc.
Target Recruit Count
8
Registration Number
NCT02137915
Locations
🇺🇸

Retina Foundation of the Southwest, Dallas, Texas, United States

Long-Term Follow-Up of Transplanted Human Central Nervous System Stem Cells (HuCNS-SC) in Spinal Cord Trauma Subjects

Terminated
Conditions
Spinal Cord Injury
Interventions
Other: Observation
First Posted Date
2012-11-14
Last Posted Date
2016-06-03
Lead Sponsor
StemCells, Inc.
Target Recruit Count
12
Registration Number
NCT01725880
Locations
🇨🇭

Uniklinik Balgrist, Zurich, Switzerland

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Phase 1
Completed
Conditions
Macular Degeneration
Age Related Macular Degeneration
AMD
Interventions
Drug: HuCNS-SC cells
First Posted Date
2012-07-03
Last Posted Date
2015-09-14
Lead Sponsor
StemCells, Inc.
Target Recruit Count
15
Registration Number
NCT01632527
Locations
🇺🇸

New York Eye and Ear Infirmary, New York, New York, United States

🇺🇸

Byers Eye Institute at Stanford, Stanford Hospital and Clinics, Palo Alto, California, United States

🇺🇸

Retina-Vitreaous Associates Medical Group, Los Angeles, California, United States

and more 2 locations

Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)

Completed
Conditions
Pelizaeus-Merzbacher Disease
PMD
Interventions
Biological: HuCNS-SC transplant in the lead-in phase
First Posted Date
2011-07-12
Last Posted Date
2016-05-13
Lead Sponsor
StemCells, Inc.
Target Recruit Count
4
Registration Number
NCT01391637
Locations
🇺🇸

UCSF Medical Center, San Francisco, California, United States

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury

Phase 1
Completed
Conditions
Spinal Cord Injury Thoracic
Spinal Cord Injury
Thoracic Spinal Cord Injury
Spinal Cord Trauma
Interventions
Biological: HuCNS-SC cells
First Posted Date
2011-03-23
Last Posted Date
2015-06-18
Lead Sponsor
StemCells, Inc.
Target Recruit Count
12
Registration Number
NCT01321333
Locations
🇨🇦

Toronto Western Hospital, Toronto, Ontario, Canada

🇨🇦

Foothills Medical Center, Calgary, Alberta, Canada

🇨🇭

University Hospital Balgrist- Uniklinik Balgrist, Forschstrasse 340, Zurich, Switzerland

Safety and Efficacy Study of HuCNS-SC in Subjects With Neuronal Ceroid Lipofuscinosis

Phase 1
Withdrawn
Conditions
Neuronal Ceroid Lipofuscinosis
Interventions
Biological: HuCNS-SC
First Posted Date
2010-11-10
Last Posted Date
2015-01-15
Lead Sponsor
StemCells, Inc.
Registration Number
NCT01238315
Locations
🇺🇸

Oregon Health and Science University, Portland, Oregon, United States

Study of Human Central Nervous System (CNS) Stem Cells Transplantation in Pelizaeus-Merzbacher Disease (PMD) Subjects

Phase 1
Completed
Conditions
Pelizaeus-Merzbacher Disease
Interventions
Biological: HuCNS-SC cells
First Posted Date
2009-10-30
Last Posted Date
2015-01-15
Lead Sponsor
StemCells, Inc.
Target Recruit Count
4
Registration Number
NCT01005004
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

Study of HuCNS-SC Cells in Patients With Infantile or Late Infantile Neuronal Ceroid Lipofuscinosis (NCL)

Phase 1
Completed
Conditions
Neuronal Ceroid Lipofuscinosis
Interventions
Procedure: Surgery to implant human CNS stem cells (HuCNS-SC)
Drug: Medication to suppress the immune system
First Posted Date
2006-06-16
Last Posted Date
2015-01-15
Lead Sponsor
StemCells, Inc.
Target Recruit Count
6
Registration Number
NCT00337636
Locations
🇺🇸

Oregon Health and Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath